Life sciences tax planning upheaval: How the OBBBA transforms your strategic approach
August 7, 2025
The One Big Beautiful Bill Act (OBBBA) transforms life sciences tax planning by restoring immediate R&E expensing, offering manufacturing incentives, and reshaping strategic decision-making for pharmaceutical, biotech, and medical device companies.
Learn More



